Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Researchers assess robotic and navigation assisted pedicle screw placement in degenerative spinal surgery

The use of robotics and computer navigation in spinal surgery is rapidly expanding. Increasing numbers of hospitals and spine surgeons are adopting the technology, which aims to enhance precision, accuracy and predictability, according to Darren R. Lebl, MD, MBA, a spine surgeon at Hospital for Special Surgery.

2 Sep 2021

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

New research has uncovered a precision medicine test using blood proteins to identify a novel patient subgroup of idiopathic multicentric Castleman disease (iMCD), a rare blood disorder, who are more likely to respond to siltuximab, the only FDA approved treatment for the disease.

2 Sep 2021

Simple blood test enables early detection of immunotherapy-triggered encephalitis

Immunotherapy is very effective for many cancers, but the treatment can also cause autoimmune side effects. Encephalitis is one of the most serious and difficult-to-diagnose side effects of immunotherapy.

2 Sep 2021

Study could help physicians better manage patients experiencing debilitating stiffness after revision TKA

A new study by researchers at Hospital for Special Surgery in New York City presented today at the American Academy of Orthopaedic Surgeons 2021 annual meeting could help physicians better manage patients who experience debilitating stiffness after they undergo knee replacement surgery.

2 Sep 2021

Simple blood test could determine the right drug, dosage for patients with rheumatoid arthritis

A simple blood test could determine which drug and dosage is more likely to be effective against rheumatoid arthritis, potentially saving sufferers serious side effects and Australian taxpayers millions of dollars.

2 Sep 2021

Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

A new study by researchers at Winship Cancer Institute of Emory University finds that cancer-associated mutations originate in blood progenitor cells, leading to distinct changes in both cancer and non-cancer immune cells in Waldenstrom macroglobulinemia (WM), a type of non-Hodgkin lymphoma and its precursor IgM monoclonal gammopathy of undetermined significance (MGUS).

2 Sep 2021

Rheumatoid arthritis drug plus standard of care may reduce COVID-19 mortality for hospitalized patients

Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.

1 Sep 2021

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

With a goal of developing rheumatoid arthritis therapies with minimal side effects, researchers at Washington University School of Medicine in St. Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.

1 Sep 2021

New study could help orthopedic surgeons to better identify patients for foot surgery

A new study by researchers at Hospital for Special Surgery in New York City could help orthopedic surgeons better identify which patients will benefit most from surgery to correct debilitating age-related deterioration of their foot arches.

31 Aug 2021

"FibroCOVID" - An emerging entity

In a recent study, a team of researchers aimed to investigate the prevalence and predictors of fibromyalgia in patients who recovered from COVID-19.

31 Aug 2021

$1.3 million in NIH funding to enable drug delivery technology research

Two National Institute of Health grants totaling over $1.3 million will enable research into antibody-mediated drug delivery technology for the treatment of cancer and autoimmune disorders. L. Nathan Tumey, assistant professor of pharmaceutical sciences at Binghamton University, State University of New York, is the Principal Investigator on both grants -; $1.2 million from the National Institute of General Medical Sciences and $150,000 from the National Institute of Allergy and Infectious Diseases.

31 Aug 2021

FDA grants seven years of marketing exclusivity for Octapharma’s Octagam 10%

Octapharma USA today announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has awarded seven years of marketing exclusivity for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis (DM).

31 Aug 2021

New evidence provides strong support for the halt on prescribing hydroxychloroquine for COVID-19

In 2021, in the United States alone, there have been more than 560,000 prescriptions of hydroxychloroquine for the prevention, post-exposure and treatment of COVID-19.

31 Aug 2021

COVID-19 vaccine elicits antibody responses in nearly 9 out of 10 people taking immunosuppressants

COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.

30 Aug 2021

Researchers study the role of low-density granulocytes in COVID-19

Information on granulocytes helps to understand mechanisms associated with covid-19 and other infectious diseases. Such information also promotes the development of better diagnostic methods and therapies.

30 Aug 2021

Researchers test remotely operated implantable drug delivery devices on the ISS

From Novartis to Lamborghini, Alessandro Grattoni and the Houston Methodist Research Institute have partnered with big names to leverage the International Space Station U.S. National Laboratory for space-based research and technology development with important benefits back on Earth.

28 Aug 2021

NYU Tandon describes novel peptide with broad therapeutic potential to combat multiple diseases

NYU Tandon professors Mary Cowman and Jin Ryoun Kim recently published a paper describing a novel peptide with broad therapeutic potential to combat chronic inflammation in multiple diseases.

28 Aug 2021

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen.

27 Aug 2021

Researchers assess the significance of rehabilitation exercises for osteoarthritis patients

Osteoarthritis is a disease of the whole joint, typified by structural alterations in bone, ligaments, and joints, that render them weak. In its severe form, it is extremely debilitating for patients, resulting in hindered mobility and the incidence of severe pain.

27 Aug 2021

NIH grant renewed to continue work at the Penn Center for Musculoskeletal Disorders

Long-time funding for work at the Penn Center for Musculoskeletal Disorders has been renewed for another five years by the National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the National Institutes of Health.

25 Aug 2021

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Researchers assess robotic and navigation assisted pedicle screw placement in degenerative spinal surgery

Research uncovers test to identify iMCD patients with superior response to FDA-approved treatment

Simple blood test enables early detection of immunotherapy-triggered encephalitis

Study could help physicians better manage patients experiencing debilitating stiffness after revision TKA

Simple blood test could determine the right drug, dosage for patients with rheumatoid arthritis

Distinct changes found in cancer and non-cancer immune cells in Waldenstrom macroglobulinemia

Rheumatoid arthritis drug plus standard of care may reduce COVID-19 mortality for hospitalized patients

Implanted cells deliver a biologic drug in response to inflammation in rheumatoid arthritis

New study could help orthopedic surgeons to better identify patients for foot surgery

"FibroCOVID" - An emerging entity

$1.3 million in NIH funding to enable drug delivery technology research

FDA grants seven years of marketing exclusivity for Octapharma’s Octagam 10%

New evidence provides strong support for the halt on prescribing hydroxychloroquine for COVID-19

COVID-19 vaccine elicits antibody responses in nearly 9 out of 10 people taking immunosuppressants

Researchers study the role of low-density granulocytes in COVID-19

Researchers test remotely operated implantable drug delivery devices on the ISS

NYU Tandon describes novel peptide with broad therapeutic potential to combat multiple diseases

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

Researchers assess the significance of rehabilitation exercises for osteoarthritis patients

NIH grant renewed to continue work at the Penn Center for Musculoskeletal Disorders

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Arthritis & Rheumatology News and Research

Latest Arthritis & Rheumatology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in